|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-2-28
|
|
pubmed:abstractText |
In a previous study we demonstrated that incompatibility regarding ligands for inhibitory killer immunoglobulin-like receptors (KIRs) is associated with a survival advantage following unrelated donor-hematopoietic cell transplantation (URD-HCT). The goal of the present analysis was to evaluate whether genotype of activating KIRs of the donor may have an impact on the outcome of URD-HCT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
287-91
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16504727-Adolescent,
pubmed-meshheading:16504727-Adult,
pubmed-meshheading:16504727-Female,
pubmed-meshheading:16504727-Genotype,
pubmed-meshheading:16504727-Graft Survival,
pubmed-meshheading:16504727-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:16504727-Humans,
pubmed-meshheading:16504727-Leukemia,
pubmed-meshheading:16504727-Lymphoma,
pubmed-meshheading:16504727-Male,
pubmed-meshheading:16504727-Receptors, Immunologic,
pubmed-meshheading:16504727-Receptors, KIR,
pubmed-meshheading:16504727-Retrospective Studies,
pubmed-meshheading:16504727-Survival Rate,
pubmed-meshheading:16504727-Tissue Donors,
pubmed-meshheading:16504727-Treatment Outcome
|
|
pubmed:articleTitle |
Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation.
|
|
pubmed:affiliation |
Department of Hematology and BMT, Silesian Medical University, ul. Reymonta 8, 40-029 Katowice, Poland. sgiebel@poczta.onet.pl
|
|
pubmed:publicationType |
Journal Article
|
